Aethlon Medical (AEMD) Competitors $0.39 -0.02 (-4.37%) Closing price 04:00 PM EasternExtended Trading$0.40 +0.00 (+0.74%) As of 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AEMD vs. OSRH, QTI, RVP, NEPH, NXGL, IRIX, CLGN, VVOS, PETV, and XAIRShould you be buying Aethlon Medical stock or one of its competitors? The main competitors of Aethlon Medical include OSR (OSRH), QT Imaging (QTI), Retractable Technologies (RVP), Nephros (NEPH), NEXGEL (NXGL), IRIDEX (IRIX), CollPlant Biotechnologies (CLGN), Vivos Therapeutics (VVOS), PetVivo (PETV), and Beyond Air (XAIR). These companies are all part of the "medical equipment" industry. Aethlon Medical vs. OSR QT Imaging Retractable Technologies Nephros NEXGEL IRIDEX CollPlant Biotechnologies Vivos Therapeutics PetVivo Beyond Air OSR (NASDAQ:OSRH) and Aethlon Medical (NASDAQ:AEMD) are both small-cap manufacturing companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, community ranking, dividends, profitability, valuation, media sentiment and analyst recommendations. Does the MarketBeat Community believe in OSRH or AEMD? Aethlon Medical received 221 more outperform votes than OSR when rated by MarketBeat users. CompanyUnderperformOutperformOSRN/AN/AAethlon MedicalOutperform Votes22150.11% Underperform Votes22049.89% Is OSRH or AEMD more profitable? OSR's return on equity of 0.00% beat Aethlon Medical's return on equity.Company Net Margins Return on Equity Return on Assets OSRN/A N/A N/A Aethlon Medical N/A -153.96%-109.13% Do analysts recommend OSRH or AEMD? Aethlon Medical has a consensus target price of $7.00, indicating a potential upside of 1,685.26%. Given Aethlon Medical's stronger consensus rating and higher probable upside, analysts plainly believe Aethlon Medical is more favorable than OSR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OSR 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aethlon Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders have more ownership in OSRH or AEMD? 55.3% of OSR shares are owned by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are owned by institutional investors. 33.7% of OSR shares are owned by insiders. Comparatively, 1.1% of Aethlon Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more risk and volatility, OSRH or AEMD? OSR has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500. Comparatively, Aethlon Medical has a beta of 1.93, indicating that its stock price is 93% more volatile than the S&P 500. Which has higher earnings & valuation, OSRH or AEMD? OSR has higher revenue and earnings than Aethlon Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOSR$4.89B0.00N/AN/AN/AAethlon Medical$570K11.05-$12.21M-$1.58-0.25 Does the media favor OSRH or AEMD? In the previous week, OSR and OSR both had 1 articles in the media. OSR's average media sentiment score of 1.38 beat Aethlon Medical's score of 0.00 indicating that OSR is being referred to more favorably in the media. Company Overall Sentiment OSR Positive Aethlon Medical Neutral SummaryOSR and Aethlon Medical tied by winning 6 of the 12 factors compared between the two stocks. Get Aethlon Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AEMD vs. The Competition Export to ExcelMetricAethlon MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.30M$4.48B$5.35B$8.38BDividend YieldN/A43.64%5.22%4.10%P/E Ratio-0.2529.8726.5819.71Price / Sales11.0568.42391.69116.98Price / CashN/A51.0838.2534.62Price / Book0.186.236.794.50Net Income-$12.21M$68.16M$3.23B$248.18M7 Day Performance-3.14%18.33%4.03%1.14%1 Month Performance19.25%23.04%12.50%15.19%1 Year Performance-8.81%20.55%16.73%6.55% Aethlon Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AEMDAethlon Medical1.7093 of 5 stars$0.39-4.4%$7.00+1,685.3%-5.0%$6.30M$570,000.00-0.2510OSRHOSRN/A$1.25flatN/AN/A$24.10M$4.89B0.00N/APositive NewsEarnings ReportGap UpQTIQT ImagingN/A$0.86-1.1%N/A+5.7%$23.34M$4.00M0.00N/ANews CoverageGap DownRVPRetractable TechnologiesN/A$0.76+0.9%N/A-21.3%$22.67M$33.05M-1.40240Gap UpNEPHNephros2.0651 of 5 stars$2.06+8.2%$5.00+143.3%+0.4%$21.78M$14.16M-22.8330Earnings ReportGap UpNXGLNEXGEL0.9182 of 5 stars$2.72+5.0%N/A+1.3%$20.82M$8.69M-4.6910Gap DownIRIXIRIDEX0.8051 of 5 stars$1.15flat$2.00+73.9%-62.2%$19.31M$48.67M-1.72120Analyst ForecastHigh Trading VolumeCLGNCollPlant Biotechnologies2.5583 of 5 stars$1.64-9.9%$12.50+662.2%-67.8%$18.79M$515,000.00-1.0670Upcoming EarningsVVOSVivos Therapeutics1.4377 of 5 stars$3.14+4.7%$6.10+94.3%-4.5%$18.50M$15.03M-0.55160Earnings ReportPETVPetVivoN/A$0.72+7.2%N/A+4.1%$17.39M$1.05M-1.5920XAIRBeyond Air4.0142 of 5 stars$0.20-0.6%$1.50+669.2%-85.3%$16.84M$3.02M-0.1870Gap Down Related Companies and Tools Related Companies OSRH Alternatives QTI Alternatives RVP Alternatives NEPH Alternatives NXGL Alternatives IRIX Alternatives CLGN Alternatives VVOS Alternatives PETV Alternatives XAIR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AEMD) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aethlon Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aethlon Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AEMD Stock Free AEMD Stock Alerts